期刊文献+

妊娠期高血压疾病凝血和纤溶实验室指标变化的临床意义 被引量:17

Clinical significance of coagulation and fibrinolysis indexes in patients with pregnancy-induced hypertension
原文传递
导出
摘要 目的检测凝血与纤溶实验室指标,探讨其在妊娠期高血压疾病(简称妊高征)诊断和预防中的价值。方法采用凝固法测定血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)和纤维蛋白原(FIB)含量;采用酶联免疫吸附试验(ELIsA)检测D-D二聚体(DD),采用发色底物法检测组织纤溶酶原激活物(tPA)、纤溶酶原激活抑制物-1(PAI-1)活性,共检测158例标本(其中重度子痫前期组44例,轻度子痫前期组32例,妊娠期高血压组30例,正常妊娠组52例),并进行比较分析。结果与正常妊娠组比较,妊娠期高血压组的PT、APTT明显降低(P<0.01),FIB、DD、PAI-1明显升高(P<0.01或P<0.05),tPA无显著差异;妊娠期高血压各组间除tPA无显著差异外,其余参数各组间差异均有统计学意义,随着疾病的加重,参数变化越显著。结论检测妊娠期高血压患者PT、APTT、FIB、DD和PAI-1等指标,对预防和治疗妊娠期高血压疾病的发生、发展有重要临床意义。 Objective To investigate the value of coagulation and fibrinolysis indexes in the diagnosis and prevention of pregnancy-induced hypertension( PIH). Methods The level of prothrombin time( PT),activated partial thromboplastin time( APTT) and fibrinogen( FIB) were tested with clotting time method,D-dimer( D-D) with ELISA,tissue-type plasminogen activator( tPA) and plasminogen activator inhibitor-1( PAI-1) with chromogenic assay. The blood samples from44 women with severe preeclampsia,32 women with mild preeclampsia,30 women with pregnancy-induced hypertension,and 52 normal pregnant women were detected and compared. Results Compared with normal pregnancy group,the levels of PT and APTT of PIH group decreased obviously( P〈0. 01),the levels of FIB,DD and PAI-1 increased obviously( P〈0. 01 or P〈0. 05),the level of tPA was not obvious. There were obvious difference in PT,APTT,DD and PAI-1 among each PIH group,and the parameters changed more significantly with the deterioration of the disease. Conclusion To monitor the changes of PT,APTT,FIB,DD and PAI-1 in patients with pregnancy induced hypertension is very important in the prevention and treatment of PIH.
出处 《中华全科医学》 2014年第9期1424-1426,共3页 Chinese Journal of General Practice
关键词 妊娠期高血压疾病 凝血 纤溶系统 Pregnancy-induced hypertension Coagulation function Fibrinolytic system
  • 相关文献

参考文献12

二级参考文献63

共引文献39

同被引文献135

  • 1刘伯宁.妊娠期高血压疾病的胎盘病理学研究进展[J].中国实用妇科与产科杂志,2004,20(10):597-599. 被引量:7
  • 2李桂玲.妊娠期高血压疾病血脂代谢改变及临床意义的探讨[J].中国医药导报,2007,4(07Z):135-136. 被引量:12
  • 3黄小芳,王明山,吴丽芳,杨丽红.孕妇血小板参数和凝血指标的变化及临床意义[J].中国实用妇科与产科杂志,2007,23(10):787-788. 被引量:12
  • 4谢幸,苟文丽.妇产科学[M].第8版.北京:人民卫生出版社,2013:258-264.
  • 5谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 6Morikawa M, Yamada T, Yamada T. Pregnancy-induced antithrombin deficiency [J]. Perinat Med, 2010, 38 ( 4 ) . 379-385.
  • 7Ehrenthal DB,Jurkovitz C, Hoffman M,et al. Prepregnan- cy body mass index as an independent risk factor for preg-nancy-induced hypertension[J]. J Women Health, 2011, 20(1) .67-72.
  • 8Ibeh N, Okocha C E, Aneke C J, et al. Normal pregnancy and coagulation profile: From the fnst through the third trimester[J].Niger J Med,2015,24( 1 ) :54-57.
  • 9Huissoud C, Carrabin N, Benchaib M, et al. Coagulation assessment by rotation thrombelastometry in normal pregnancy [J]. Thromb Haemost,2009,101 (4) :755-761.
  • 10Karlsson O, Sporrong T, Hillarp A, et al. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy[J]. Anesth Analg,2012, 115(4) :890-898.

引证文献17

二级引证文献193

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部